Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

RSS icon
money business cash flow dollar

AstraZeneca spends up to $1.9B for new heart disease drug

Early data suggest the drug, an oral lipoprotein (a) disruptor, could make a significant impact on patient care. AstraZeneca will pay $100 million upfront, with much more to follow if certain milestones are met. 

Medtronic's MiniMed 780 (left) and 670 (right) insulin pumps in FDA recall

FDA rules Medtronic’s insulin pump issues a Class I recall due to safety risks

Some of Medtronic's 600 and 700 series MiniMed insulin pumps are experiencing significant battery issues when dropped, bumped or impacted in any way. This has been linked to reports of health issues in more than 180 patients.

5:2 intermittent fasting diet

It’s not what you eat, but when: Intermittent fasting boosts heart health of high-risk patients

“Unlike expensive pharmaceuticals like Ozempic, which require lifetime use, time-restricted eating is a simple lifestyle change that does not cause side effects and can be maintained indefinitely,” one doctor explained. 

Do cancer treatments increase a patient's risk of cardiovascular disease?

Older cancer survivors appear to face higher risks of stroke, heart attack and heart failure. Early screening and preventative measures can help.

voice audio recording smartphone

AI detects hypertension in voice recordings

A machine learning-powered smartphone app was trained to detect hundreds of biomarkers in the human voice, using even the tiniest detail to anticipate when patients may present with symptoms of hypertension. 

Thumbnail

Watchdog group, fearful of fraud, wants more oversight for remote patient monitoring

Cardiologists and other physicians may soon need to provide much more information when ordering remote patient monitoring for Medicare patients.

Heart tissues within one of the Johns Hopkins space launch-ready chambers for study aboard the International Space Station. Photo from Jonathan Tsui.

Space travel disrupts normal rhythm in heart cells

Heart tissue samples that spent 30 days at the International Space Station appear to have been weakened by the low gravity conditions in space. This finding has implications for the heart health of astronauts.

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

Most recalled cardiovascular devices gained FDA approval with little to no clinical evidence

Why are so many cardiovascular devices involved in Class I recalls? One possible reason could be the large number of devices hitting the market without undergoing much premarket clinical testing. 

Displaying 65 - 72 of 1005
Design by Adaptive Theme